Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the longterm safety and efficacy of the vaginal
application of Gynoflor®, an extremely low dosed estrogen therapy with lactobacilli, on
atrophic vaginitis in postmenopausal breast cancer patients who have been treated with
aromatase inhibitors.